- Home
- FOLD vs CVBF Comparison
FOLD vs CVBF Comparison
Compare FOLD & CVBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOLD
- CVBF
- Stock Information
- Founded
- FOLD 2002
- CVBF 1974
- Country
- FOLD United States
- CVBF United States
- Employees
- FOLD 499
- CVBF N/A
- Industry
- FOLD Biotechnology: Pharmaceutical Preparations
- CVBF Major Banks
- Sector
- FOLD Health Care
- CVBF Finance
- Exchange
- FOLD Nasdaq
- CVBF Nasdaq
- Market Cap
- FOLD 2.5B
- CVBF 2.7B
- IPO Year
- FOLD 2007
- CVBF N/A
- Fundamental
- Price
- FOLD $8.42
- CVBF $19.04
- Analyst Decision
- FOLD Strong Buy
- CVBF Buy
- Analyst Count
- FOLD 9
- CVBF 4
- Target Price
- FOLD $26.44
- CVBF $23.25
- AVG Volume (30 Days)
- FOLD 5.3M
- CVBF 693.8K
- Earning Date
- FOLD 11-05-2025
- CVBF 10-22-2025
- Dividend Yield
- FOLD N/A
- CVBF 4.31%
- EPS Growth
- FOLD N/A
- CVBF N/A
- EPS
- FOLD N/A
- CVBF 1.46
- Revenue
- FOLD $571,160,000.00
- CVBF $507,999,000.00
- Revenue This Year
- FOLD $21.04
- CVBF N/A
- Revenue Next Year
- FOLD $21.34
- CVBF $5.65
- P/E Ratio
- FOLD N/A
- CVBF $12.70
- Revenue Growth
- FOLD 25.35
- CVBF N/A
- 52 Week Low
- FOLD $5.51
- CVBF $16.01
- 52 Week High
- FOLD $12.65
- CVBF $24.58
- Technical
- Relative Strength Index (RSI)
- FOLD 57.84
- CVBF 49.33
- Support Level
- FOLD $7.87
- CVBF $17.95
- Resistance Level
- FOLD $8.49
- CVBF $19.47
- Average True Range (ATR)
- FOLD 0.37
- CVBF 0.50
- MACD
- FOLD -0.03
- CVBF 0.02
- Stochastic Oscillator
- FOLD 81.67
- CVBF 71.71
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
About CVBF CVB Financial Corporation
CVB Financial Corp is the holding company for Citizens Business Bank. Citizens Business Bank offers banking, lending, and investing services. It provides a full complement of lending products, including commercial, agribusiness, consumer, SBA, real estate, and construction loans, as well as equipment and vehicle leasing. Commercial products include lines of credit and other working capital financing, accounts receivable lending and letters of credit.